National Cancer Center, Korea
Clinical trials sponsored by National Cancer Center, Korea, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New combo aims to stop breast cancer return after failed chemo Results expected Dec 2026 (estimated)
- New drug combo targets tough adrenal cancer Results expected Feb 2027 (estimated)
- New hope for rare pancreatic cancer: experimental drug enters trial Results expected Mar 2027 (estimated)
- Exercise may ease Chemo's nerve pain, new study hopes to prove Results expected Jul 2027 (estimated)